Mehmet Sevki Uyanik, M.D.

Dr. Mehmet Sevki Uyanik is a board-eligible hematologist-oncologist. He has more than a decade of clinical experience in hematology and oncology across academic and private healthcare settings, with particular expertise in malignant hematologic disorders and hematopoietic stem cell transplantation and cellular therapies (CAR T-Cell, CAR NK-Cell and TIL).





Dr. Uyanık earned his medical degree from Uludag University Faculty of Medicine in Türkiye. He then completed his internal medicine residency and hematology fellowship at Trakya University Faculty of Medicine. Following his core training, he practiced as a hematologist-oncologist in university and private hospital settings and served as an Assistant Professor of Medicine. He subsequently pursued advanced subspecialty training through a Leukemia Fellowship at The University of Texas MD Anderson Cancer Center in Houston, where he contributed to clinical research in acute myeloid leukemia, high-risk myelodysplastic syndromes, and related myeloid neoplasms, followed by a Bone Marrow Transplantation and Cellular Therapy Fellowship at Mayo Clinic in Jacksonville, Florida.





Dr. Uyanık's clinical and research interests include bone marrow transplantation, CAR T-cell therapy, multiple myeloma, amyloidosis, POEMS, Waldenström macroglobulinemia, acute myeloid leukemia, high-risk myelodysplastic syndromes, chronic myeloid leukemia, tumor-infiltrating lymphocyte therapy, and the application of cellular therapies to autoimmune diseases. He is particularly interested in integrating transplantation and emerging cellular and immune-based therapies into personalized, evidence-based patient care.





His academic work includes peer-reviewed publications and international presentations spanning leukemia, myelodysplastic syndromes, chronic myeloid leukemia, lymphoid malignancies, plasma cell disorders, and transplantation. He received a 2025 ASCO Annual Meeting Merit Award and has participated as a principal investigator and co-investigator in multiple funded research projects. Dr. Uyanık is committed to advancing hematologic care through clinical research, multidisciplinary collaboration, medical education, and compassionate, patient-centered practice.